The influence of gut microbiota in cardiovascular diseases—a brief review
Open Access
- 1 January 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 6 (1) , e106
Abstract
Lately, the gut microbiota has emerged as an important mediator of the development and the outcomes of certain diseases. It's well known that the gut microbiota plays an important role in maintaining human health. Still far from being completely understood and analyzed is the complexity of this ecosystem, although a close relationship between the gut microbiota and cardiovascular diseases (CVD) has been established. A loss of diversity in the microbiota will lead to physiological changes, which can improve inflammatory or infection states like atherosclerosis and hypertension, the basic pathological process of CVD. Targeting the gut microbiota and its metabolites are new and promising strategies for the treatment and prognosis of CVD.Keywords
This publication has 35 references indexed in Scilit:
- The Role of Microbiota on the Gut ImmunologyClinical Therapeutics, 2015
- New Aspects on the Metabolic role of Intestinal Microbiota in the Development of AtherosclerosisMetabolism, 2015
- Attenuated portal hypertension in germ‐free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vesselsHepatology, 2015
- The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic DiseasesAnnual Review of Medicine, 2015
- Diet rapidly and reproducibly alters the human gut microbiomeNature, 2013
- Foam cells in atherosclerosisClinica Chimica Acta, 2013
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?Journal of Obesity, 2012
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Prebiotic effects: metabolic and health benefitsBritish Journal of Nutrition, 2010